Literature DB >> 2014882

HIV infection among women entering the New York State correctional system.

P F Smith, J Mikl, B I Truman, L Lessner, J S Lehman, R W Stevens, E A Lord, R K Broaddus, D L Morse.   

Abstract

Human immunodeficiency virus infection is the leading medical problem among prison inmates in several states. In 1988 a blinded seroprevalence study was conducted on 480 New York female prison entrants to determine the prevalence of and risk factors for HIV infection in this population. Ninety (18.8 percent) women were HIV-seropositive. Seroprevalence was highest among women ages 30-39 (25.0 percent) and varied by ethnicity (Hispanics, 29.4 percent; Blacks, 14.4 percent; Whites, 7.1 percent) and residence (New York City, 23.8 percent; Upstate, 5.1 percent). Nearly half (44.9 percent) of the 136 acknowledged intravenous drug users and one-third (33.8 percent) of the 71 women with a positive syphilis serology were HIV-seropositive. There was no difference in fertility histories between seropositive and seronegative women, and two of 21 pregnant women were seropositive. This study led to increased clinical and prevention services for this high-risk population.

Entities:  

Mesh:

Year:  1991        PMID: 2014882      PMCID: PMC1404753          DOI: 10.2105/ajph.81.suppl.35

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  13 in total

1.  Projection of AIDS incidence in women in New York State.

Authors:  L Lessner
Journal:  Am J Public Health       Date:  1991-05       Impact factor: 9.308

2.  Cocaine use and HIV infection in intravenous drug users in San Francisco.

Authors:  R E Chaisson; P Bacchetti; D Osmond; B Brodie; M A Sande; A R Moss
Journal:  JAMA       Date:  1989-01-27       Impact factor: 56.272

3.  Increasing incidence of tuberculosis in a prison inmate population. Association with HIV infection.

Authors:  M M Braun; B I Truman; B Maguire; G T DiFerdinando; G Wormser; R Broaddus; D L Morse
Journal:  JAMA       Date:  1989-01-20       Impact factor: 56.272

4.  Investigations of AIDS patients with no previously identified risk factors.

Authors:  K G Castro; A R Lifson; C R White; T J Bush; M E Chamberland; A M Lekatsas; H W Jaffe
Journal:  JAMA       Date:  1988-03-04       Impact factor: 56.272

5.  Temporal trends of human immunodeficiency virus type 1 (HIV-1) infection among inmates entering a statewide prison system, 1985-1987.

Authors:  D Vlahov; F Brewer; A Muñoz; D Hall; E Taylor; B F Polk
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

6.  Does infection with HIV affect the outcome of pregnancy?

Authors:  F D Johnstone; L MacCallum; R Brettle; J M Inglis; J F Peutherer
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-13

7.  Risk factors for human immunodeficiency virus infection in intravenous drug users.

Authors:  E E Schoenbaum; D Hartel; P A Selwyn; R S Klein; K Davenny; M Rogers; C Feiner; G Friedland
Journal:  N Engl J Med       Date:  1989-09-28       Impact factor: 91.245

8.  HIV infection among persons who inject illicit drugs: problems and prospects.

Authors:  D C Des Jarlais; S R Friedman
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1988

9.  The association between genital ulcer disease and acquisition of HIV infection in homosexual men.

Authors:  W E Stamm; H H Handsfield; A M Rompalo; R L Ashley; P L Roberts; L Corey
Journal:  JAMA       Date:  1988-09-09       Impact factor: 56.272

10.  Genital ulceration as a risk factor for human immunodeficiency virus infection.

Authors:  R M Greenblatt; S A Lukehart; F A Plummer; T C Quinn; C W Critchlow; R L Ashley; L J D'Costa; J O Ndinya-Achola; L Corey; A R Ronald
Journal:  AIDS       Date:  1988-02       Impact factor: 4.177

View more
  12 in total

1.  HIV and AIDS risk behaviors among female jail detainees: implications for public health policy.

Authors:  Gary Michael McClelland; Linda A Teplin; Karen M Abram; Naomi Jacobs
Journal:  Am J Public Health       Date:  2002-05       Impact factor: 9.308

2.  Projection of AIDS incidence in women in New York State.

Authors:  L Lessner
Journal:  Am J Public Health       Date:  1991-05       Impact factor: 9.308

3.  From corrections to communities as an HIV priority.

Authors:  David Vlahov; Sara Putnam
Journal:  J Urban Health       Date:  2006-05       Impact factor: 3.671

Review 4.  The HIV Care Cascade Before, During, and After Incarceration: A Systematic Review and Data Synthesis.

Authors:  Princess A Iroh; Helen Mayo; Ank E Nijhawan
Journal:  Am J Public Health       Date:  2015-05-14       Impact factor: 9.308

5.  HIV seroprevalence surveys: impetus for preventive activities.

Authors:  L F Novick
Journal:  Am J Public Health       Date:  1991-05       Impact factor: 9.308

6.  Sources of heterogeneity in hepatitis B virus (HBV) seroprevalence estimates from U.S. adult incarcerated populations: A systematic review and meta-regression analysis.

Authors:  Amy J Harzke; Karen J Goodman; Patricia D Mullen; Jacques Baillargeon
Journal:  Int J Prison Health       Date:  2010-06

7.  HIV infection in the Women's Jail, Orange County, California, 1985 through 1991.

Authors:  G A Gellert; R M Maxwell; K V Higgins; T Pendergast; N Wilker
Journal:  Am J Public Health       Date:  1993-10       Impact factor: 9.308

8.  Predictive factors of HIV-infection in injecting drug users upon incarceration.

Authors:  V Martín; J A Caylà; M L Morís; L E Alonso; R Pérez
Journal:  Eur J Epidemiol       Date:  1998-06       Impact factor: 8.082

9.  HIV infection among women in prison: an assessment of risk factors using a nonnominal methodology.

Authors:  C A Hankins; S Gendron; M A Handley; C Richard; M T Tung; M O'Shaughnessy
Journal:  Am J Public Health       Date:  1994-10       Impact factor: 9.308

10.  Prevalence and determinants of high-risk human papillomavirus (HPV) infection and cervical cytological abnormalities in imprisoned women.

Authors:  C González; J Canals; M Ortiz; L Muñoz; M Torres; A García-Saiz; J Del Amo
Journal:  Epidemiol Infect       Date:  2007-04-20       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.